82 related articles for article (PubMed ID: 21802486)
1. Substrate specificity of Staphylococcus aureus cysteine proteases--Staphopains A, B and C.
Kalińska M; Kantyka T; Greenbaum DC; Larsen KS; Władyka B; Jabaiah A; Bogyo M; Daugherty PS; Wysocka M; Jaros M; Lesner A; Rolka K; Schaschke N; Stennicke H; Dubin A; Potempa J; Dubin G
Biochimie; 2012 Feb; 94(2):318-27. PubMed ID: 21802486
[TBL] [Abstract][Full Text] [Related]
2. α1-Antichymotrypsin inactivates staphylococcal cysteine protease in cross-class inhibition.
Wladyka B; Kozik AJ; Bukowski M; Rojowska A; Kantyka T; Dubin G; Dubin A
Biochimie; 2011 May; 93(5):948-53. PubMed ID: 21296644
[TBL] [Abstract][Full Text] [Related]
3. Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus.
Ohbayashi T; Irie A; Murakami Y; Nowak M; Potempa J; Nishimura Y; Shinohara M; Imamura T
Microbiology (Reading); 2011 Mar; 157(Pt 3):786-792. PubMed ID: 21081759
[TBL] [Abstract][Full Text] [Related]
4. Papain-like proteases of Staphylococcus aureus.
Kantyka T; Shaw LN; Potempa J
Adv Exp Med Biol; 2011; 712():1-14. PubMed ID: 21660655
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of human extracellular cysteine protease inhibitors by the secreted staphylococcal cysteine proteases, staphopain A and B.
Vincents B; Onnerfjord P; Gruca M; Potempa J; Abrahamson M
Biol Chem; 2007 Apr; 388(4):437-46. PubMed ID: 17391065
[TBL] [Abstract][Full Text] [Related]
6. Crystal Structure of Staphopain C from
Magoch M; McEwen AG; Napolitano V; Władyka B; Dubin G
Molecules; 2023 May; 28(11):. PubMed ID: 37298883
[No Abstract] [Full Text] [Related]
7. Human SCCA serpins inhibit staphylococcal cysteine proteases by forming classic "serpin-like" covalent complexes.
Kantyka T; Potempa J
Methods Enzymol; 2011; 499():331-45. PubMed ID: 21683261
[TBL] [Abstract][Full Text] [Related]
8. Defense against own arms: staphylococcal cysteine proteases and their inhibitors.
Dubin G
Acta Biochim Pol; 2003; 50(3):715-24. PubMed ID: 14515151
[TBL] [Abstract][Full Text] [Related]
9. Genetic characterization of staphopain genes in Staphylococcus aureus.
Golonka E; Filipek R; Sabat A; Sinczak A; Potempa J
Biol Chem; 2004 Nov; 385(11):1059-67. PubMed ID: 15576326
[TBL] [Abstract][Full Text] [Related]
10. The staphostatin family of cysteine protease inhibitors in the genus Staphylococcus as an example of parallel evolution of protease and inhibitor specificity.
Dubin G; Wladyka B; Stec-Niemczyk J; Chmiel D; Zdzalik M; Dubin A; Potempa J
Biol Chem; 2007 Feb; 388(2):227-35. PubMed ID: 17261086
[TBL] [Abstract][Full Text] [Related]
11. Prostaphopain B structure: a comparison of proregion-mediated and staphostatin-mediated protease inhibition.
Filipek R; Szczepanowski R; Sabat A; Potempa J; Bochtler M
Biochemistry; 2004 Nov; 43(44):14306-15. PubMed ID: 15518582
[TBL] [Abstract][Full Text] [Related]
12. Growth phase-dependent production of a cell wall-associated elastinolytic cysteine proteinase by Staphylococcus epidermidis.
Oleksy A; Golonka E; Bańbuła A; Szmyd G; Moon J; Kubica M; Greenbaum D; Bogyo M; Foster TJ; Travis J; Potempa J
Biol Chem; 2004 Jun; 385(6):525-35. PubMed ID: 15255185
[TBL] [Abstract][Full Text] [Related]
13. Fighting an enemy within: cytoplasmic inhibitors of bacterial cysteine proteases.
Potempa J; Golonka E; Filipek R; Shaw LN
Mol Microbiol; 2005 Aug; 57(3):605-10. PubMed ID: 16045606
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into the substrate specificity and activity of ervatamins, the papain-like cysteine proteases from a tropical plant, Ervatamia coronaria.
Ghosh R; Chakraborty S; Chakrabarti C; Dattagupta JK; Biswas S
FEBS J; 2008 Feb; 275(3):421-34. PubMed ID: 18167146
[TBL] [Abstract][Full Text] [Related]
15. Staphopains modulate Staphylococcus aureus biofilm integrity.
Mootz JM; Malone CL; Shaw LN; Horswill AR
Infect Immun; 2013 Sep; 81(9):3227-38. PubMed ID: 23798534
[TBL] [Abstract][Full Text] [Related]
16. Efficient co-expression of a recombinant staphopain A and its inhibitor staphostatin A in Escherichia coli.
Wladyka B; Puzia K; Dubin A
Biochem J; 2005 Jan; 385(Pt 1):181-7. PubMed ID: 15320867
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Staphopain A (ScpA) and B (SspB) precursor activation mechanisms reveals unique secretion kinetics of proSspB (Staphopain B), and a different interaction with its cognate Staphostatin, SspC.
Nickerson N; Ip J; Passos DT; McGavin MJ
Mol Microbiol; 2010 Jan; 75(1):161-77. PubMed ID: 19943908
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Staphylococcus aureus cysteine proteases by human serpin potentially limits staphylococcal virulence.
Kantyka T; Plaza K; Koziel J; Florczyk D; Stennicke HR; Thogersen IB; Enghild JJ; Silverman GA; Pak SC; Potempa J
Biol Chem; 2011 May; 392(5):483-9. PubMed ID: 21476872
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic activity of the Staphylococcus aureus SplB serine protease is induced by substrates containing the sequence Trp-Glu-Leu-Gln.
Dubin G; Stec-Niemczyk J; Kisielewska M; Pustelny K; Popowicz GM; Bista M; Kantyka T; Boulware KT; Stennicke HR; Czarna A; Phopaisarn M; Daugherty PS; Thøgersen IB; Enghild JJ; Thornberry N; Dubin A; Potempa J
J Mol Biol; 2008 May; 379(2):343-56. PubMed ID: 18448121
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding.
Vincents B; von Pawel-Rammingen U; Björck L; Abrahamson M
Biochemistry; 2004 Dec; 43(49):15540-9. PubMed ID: 15581366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
